Become part of a team who are dedicated to enhancing and connecting primary healthcare to achieve better health outcomes for the South Western Sydney community.
Find your next South Western Sydney general practice career or practice for sale.
Practice vacancy ad request form
Practice for sale formKey points:
- From Monday, 3 February 2025 a new RSV maternal vaccine, Abrysvo®, will be available on the National Immunisation Program (NIP) for pregnant women from 28 to 36 weeks gestation.
- Maternal vaccination with Abrysvo® protects newborn babies from severe RSV in the first six months of life through the transfer of maternal antibodies to the foetus during pregnancy.
- Abrysvo® is the only RSV vaccine approved for use in pregnant women. (Note: Arexvy® vaccine should not be given to pregnant women.)
- A single dose of Abrysvo® should be offered to all pregnant women year round at the 28-week antenatal appointment and can be given at the same time as pertussis and influenza vaccines.
- From 17 March 2025, infants not protected from RSV by maternal vaccination or who have certain medical risk factors for severe RSV disease, will be offered nirsevimab, a monoclonal antibody.
As part of the NSW RSV Prevention Program, NSW Health advise health professionals Abrysvo®, a new RSV maternal vaccine, will be available on the National Immunisation Program (NIP) for pregnant women from 28 to 36 weeks gestation from 3 February 2025.
The new NSW RSV Prevention Program aims to protect newborn and at-risk infants against RSV and reduce RSV-associated infections and hospitalisations through the transfer of maternal antibodies to the fetus during pregnancy, or provision of passive immunisation to infants not protected by maternal vaccination and eligible at-risk infants.
NSW Health have issued a fact sheet providing advice for health professionals. Download the fact sheet for recommendations on timing, where to find clinical decision aids, ordering supplies and reporting in the Australian Immunisation Register (AIR) and “yellow” antenatal card.
Read NSW Health Fact Sheet for health professionalsVisit NSW Health for the latest NSW RSV Prevention Program guidance for health professionals.
NCISRS Webinar
Title: Australian RSV immunisation update – new funded programs for infant protection
Hosted by: National Centre for Immunisation Research and Surveillance (NCIRS)
When: 12.00–1.30pm, Thursday, 6 February 2025.
This NCIRS webinar will explore RSV disease and prevention and expand on the new funded RSV programs. Our panel of leading experts will present on:
- RSV disease in infants and young children
- effectiveness and safety of RSV vaccination and long-acting monoclonal antibody
- the new NIP-funded RSV vaccination program for pregnant women to protect their infants
- complementary state- and territory-funded RSV long-acting monoclonal antibody programs
- RSV prevention program resources to support healthcare providers.
A live Q&A session will follow the presentations and audience participation is encouraged.
The event will be recorded and made available on the NCIRS website in the days following the webinar. Register to receive the link to the recording via email when it becomes available.
Webinar RegistrationOr view the NSW Health RSV Prevention Program webinar held 6 November 2024.
SWSLHD Antenatal GPSC Clinical Midwife Consultant has compiled key points of the NSW RSV Prevention Program in the below poster.